Enters the Board of CytoVac

Posted on Posted in Uncategorized

Per Falholt has entered the board of the Biotek company Cytovac which develops new cancer therapies based on the patient’s own cells, helping the immune system to fight the disease.

Leave a Reply

Your email address will not be published. Required fields are marked *